Blueprint for EECA countries, first edition
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
DHS ANALYTICAL STUDIES 56
Bangladesh, Cambodia, India, Indonesia, Nepal, Pakistan, Philippines
The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules
- Essential Care and Practice that includes general guid...elines and Iminterventions and implementation module to support the proposed interventions by necessary infrastructure and resources; and, revised modules for Psychoses, Child and Adolescent Mental and Behavioural Disorders and Disorders due to Substance Use
more
Guide pratique à l’usage des sages-femmes, médecins spécialisés en obstétrique et personnel de santé devant faire face à des urgences obstétricales. Ce guide a été conçu comme un outil qui permette de protéger la mère et son enfant dans un environnement défavorable. Il est destiné a...ux sages-femmes, médecins spécialisés en obstétrique et personnel de santé devant faire face à des urgences obstétricales.
more
Essential obstetric and newborn care is designed as a tool to help protect mothers and their children in adverse environments. It is intended for midwives, doctors with obstetrics training, and health care personnel who deal with obstetric emergencies.
DHS Further Analysis Reports No 102
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
Policy Brief
Accessed: 20.11.2019